How to buy NantHealth stock - 12 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy NantHealth stock

Own NantHealth stock in just a few minutes.

NantHealth, Inc is a health information services business based in the US. NantHealth shares (NH) are listed on the NASDAQ and all prices are listed in US Dollars. NantHealth employs 352 staff and has a trailing 12-month revenue of around USD$73.2 million.

How to buy shares in NantHealth

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for NantHealth. Find the stock by name or ticker symbol: NH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until NantHealth reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of NantHealth, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of NantHealth. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

NantHealth share price

Use our graph to track the performance of NH stocks over time.

NantHealth shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$1.61 - USD$6.39
50-day moving average USD$3.6035
200-day moving average USD$3.122
Wall St. target priceUSD$3.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.651

Buy NantHealth shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NantHealth stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NantHealth financials

Revenue TTM USD$73.2 million
Gross profit TTM USD$48.7 million
Return on assets TTM -6.84%
Return on equity TTM 0%
Profit margin -76.98%
Book value $-0.276
Market capitalisation USD$372.9 million

TTM: trailing 12 months

Shorting NantHealth shares

There are currently 1.9 million NantHealth shares held short by investors – that's known as NantHealth's "short interest". This figure is 3.8% up from 1.8 million last month.

There are a few different ways that this level of interest in shorting NantHealth shares can be evaluated.

NantHealth's "short interest ratio" (SIR)

NantHealth's "short interest ratio" (SIR) is the quantity of NantHealth shares currently shorted divided by the average quantity of NantHealth shares traded daily (recently around 383285.68507157). NantHealth's SIR currently stands at 4.89. In other words for every 100,000 NantHealth shares traded daily on the market, roughly 4890 shares are currently held short.

However NantHealth's short interest can also be evaluated against the total number of NantHealth shares, or, against the total number of tradable NantHealth shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NantHealth's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 NantHealth shares in existence, roughly 20 shares are currently held short) or 0.0681% of the tradable shares (for every 100,000 tradable NantHealth shares, roughly 68 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NantHealth.

Find out more about how you can short NantHealth stock.

NantHealth share dividends

We're not expecting NantHealth to pay a dividend over the next 12 months.

NantHealth share price volatility

Over the last 12 months, NantHealth's shares have ranged in value from as little as $1.61 up to $6.39. A popular way to gauge a stock's volatility is its "beta".

NH.US volatility(beta: 1.69)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NantHealth's is 1.6892. This would suggest that NantHealth's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

NantHealth overview

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers GPS Cancer, a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing; Omics Core, an in-vitro diagnostic built on a custom-targeted whole exome sequencing platform; and Quadris, a data solution that includes multi-data analysis, reporting, and professional service. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site